Cargando…

Ferroptosis: roles and molecular mechanisms in diabetic cardiomyopathy

Diabetic cardiomyopathy (DCM) is a serious complication of type 1 and type 2 diabetes, which leads to the aggravation of myocardial fibrosis, disorders involving systolic and diastolic functions, and increased mortality of patients with diabetes through mechanisms such as glycolipid toxicity, inflam...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhao, Yangting, Pan, Binjing, Lv, Xiaoyu, Chen, Chongyang, Li, Kai, Wang, Yawen, Liu, Jingfang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157477/ https://www.ncbi.nlm.nih.gov/pubmed/37152931 http://dx.doi.org/10.3389/fendo.2023.1140644

Ejemplares similares

Research progress on the mechanism of ferroptosis and its role in diabetic retinopathy
por: He, Wei, et al.
Publicado: (2023)

Canagliflozin mitigates ferroptosis and improves myocardial oxidative stress in mice with diabetic cardiomyopathy
por: Du, Shuqin, et al.
Publicado: (2022)

Ferroptosis: new insight into the mechanisms of diabetic nephropathy and retinopathy
por: Li, Luxin, et al.
Publicado: (2023)

Identification of ferroptosis-related molecular clusters and genes for diabetic osteoporosis based on the machine learning
por: Wang, Xingkai, et al.
Publicado: (2023)

Endothelial Dysfunction and Diabetic Cardiomyopathy
por: Wang, Moran, et al.
Publicado: (2022)

Research progress on ferroptosis in diabetic kidney disease
por: Wu, You, et al.
Publicado: (2022)

Central role of cardiac fibroblasts in myocardial fibrosis of diabetic cardiomyopathy
por: Cheng, Yanan, et al.
Publicado: (2023)

Ferroptosis and its potential role in gestational diabetes mellitus: updated evidence from pathogenesis to therapy
por: Zhao, Yan, et al.
Publicado: (2023)

Diabetic cardiomyopathy: Clinical phenotype and practice
por: Zhao, Xudong, et al.
Publicado: (2022)

Ferroptosis and Its Potential Role in Glioma: From Molecular Mechanisms to Therapeutic Opportunities
por: Luo, Yusong, et al.
Publicado: (2022)

Identification of potential ferroptosis-related biomarkers and a pharmacological compound in diabetic retinopathy based on machine learning and molecular docking
por: Liu, Jingying, et al.
Publicado: (2022)

Integrated bioinformatic analysis reveals immune molecular markers and potential drugs for diabetic cardiomyopathy
por: Guo, Qixin, et al.
Publicado: (2022)

Bioinformatics analysis identifies potential ferroptosis key genes in the pathogenesis of diabetic peripheral neuropathy
por: Tian, Ming, et al.
Publicado: (2023)

Effect of transferrin glycation induced by high glucose on HK-2 cells in vitro
por: Ma, Yanqi, et al.
Publicado: (2023)

Epigenetics of methylation modifications in diabetic cardiomyopathy
por: Hao, Jing, et al.
Publicado: (2023)

Spotlight on iron and ferroptosis: research progress in diabetic retinopathy
por: Ouyang, Junlin, et al.
Publicado: (2023)

Diabetic cardiomyopathy: The role of microRNAs and long non-coding RNAs
por: Macvanin, Mirjana T., et al.
Publicado: (2023)

Histone Deacetylases in the Pathogenesis of Diabetic Cardiomyopathy
por: Ke, Xiangyu, et al.
Publicado: (2021)

Diabetic Cardiomyopathy: An Immunometabolic Perspective
por: Mishra, Paras K., et al.
Publicado: (2017)

Molecular mechanisms of ferroptosis and its role in cancer therapy
por: Xu, Tao, et al.
Publicado: (2019)

The mechanisms crosstalk and therapeutic opportunities between ferroptosis and ovary diseases
por: Yao, Ying, et al.
Publicado: (2023)

Ferroptosis as a Novel Therapeutic Target for Diabetes and Its Complications
por: Yang, Xi-Ding, et al.
Publicado: (2022)

Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy
por: Wei, Maoying, et al.
Publicado: (2023)

Myocardial protection of S-nitroso-L-cysteine in diabetic cardiomyopathy mice
por: Peng, Lulu, et al.
Publicado: (2022)

Cardiovascular-renal protective effect and molecular mechanism of finerenone in type 2 diabetic mellitus
por: Lv, Ruolin, et al.
Publicado: (2023)

Emerging Role of Ferroptosis in Diabetic Kidney Disease: Molecular Mechanisms and Therapeutic Opportunities
por: Wang, Hui, et al.
Publicado: (2023)

Emerging Roles of Dyslipidemia and Hyperglycemia in Diabetic Retinopathy: Molecular Mechanisms and Clinical Perspectives
por: Rao, Hussain, et al.
Publicado: (2021)

Role of Dapagliflozin and Liraglutide on Diabetes-Induced Cardiomyopathy in Rats: Implication of Oxidative Stress, Inflammation, and Apoptosis
por: El-Shafey, Mohamed, et al.
Publicado: (2022)

In silico identification and verification of ferroptosis-related genes in type 2 diabetic islets
por: Yin, Meiqi, et al.
Publicado: (2022)

Molecular mechanism of ferroptosis and its role in the occurrence and treatment of diabetes
por: Du, Guanghui, et al.
Publicado: (2022)

Diabetic Muscular Atrophy: Molecular Mechanisms and Promising Therapies
por: Shen, Yuntian, et al.
Publicado: (2022)

Signaling Pathways Related to Oxidative Stress in Diabetic Cardiomyopathy
por: Peng, Meng-ling, et al.
Publicado: (2022)

Molecular Mechanisms of Glucose Fluctuations on Diabetic Complications
por: Zhang, Zhen-Ye, et al.
Publicado: (2019)

Editorial: Progression to Diabetes: Molecular and cellular mechanisms
por: Guillén, Carlos, et al.
Publicado: (2023)

Editorial: Insights in diabetes: molecular mechanisms 2022
por: Rao, Gundu H. R.
Publicado: (2023)

Diabetes mellitus promotes susceptibility to periodontitis—novel insight into the molecular mechanisms
por: Zhao, Mingcan, et al.
Publicado: (2023)

Bioinformatics Analysis Identifies Potential Ferroptosis Key Gene in Type 2 Diabetic Islet Dysfunction
por: Ye, Haowen, et al.
Publicado: (2022)

An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy
por: Bai, Zhenyu, et al.
Publicado: (2022)

Association Between the Risk of Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes and Chronic Kidney Disease
por: Zhao, Pingping, et al.
Publicado: (2022)

Chronic O-GlcNAcylation and Diabetic Cardiomyopathy: The Bitterness of Glucose
por: Ducheix, Simon, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_olsp0mb71cfl1c0u2un4f1r5c4